You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 9, September 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •External Eye Disease
 •Alert me on articles by topic

Topical Cyclosporin in the Treatment of Chronic Sarcoidosis of the Conjunctiva

Arch Ophthalmol. 2003;121:1333-1335.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Sarcoidosis is a multisystem, T-lymphocyte–mediated granulomatous inflammatory process of unknown cause. The clinical spectrum varies in severity from single-organ involvement and self-limiting disease to multisystem inflammation with potential mortality. The characteristic noncaseating granulomatous infiltrations can affect almost any tissue, including conjunctivae.1 The granulomatous inflammation of the conjunctivae in the form of conjunctival nodules resembling follicular conjunctivitis is a common initial finding.2 We describe a patient with chronic conjunctivitis who was subsequently diagnosed as having sarcoidosis and successfully treated with topical cyclosporin.

Report of a Case

A 58-year-old white woman was referred for further management of ocular rosacea and keratoconjunctivitis sicca, which had been refractory to treatment with multiple medications, including oral and topical doxycycline, 1% topical prednisolone acetate, 0.5% ketorolac tromethamine, 0.1% olopatadine hydrochloride, and preservative-free artificial tears for 7 months. Her ocular history was remarkable for primary open-angle glaucoma, for which she underwent a bilateral laser trabeculoplasty 1 year prior to our initial . . . [Full Text of this Article]


Comment
Esen Karamursel Akpek, MD; Ozge Ilhan-Sarac, MD; W. Richard Green, MD
Baltimore, Md

Corresponding author and reprints: Esen Karamursel Akpek, MD, Wilmer Eye Institute, 600 N Wolfe St, Maumenee Bldg 321, Baltimore, MD 21287-9238 (e-mail: esakpek@jhmi.edu).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Topical ciclosporin in the treatment of ocular surface disorders
Tatlipinar and Akpek
Br. J. Ophthalmol. 2005;89:1363-1367.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.